Puma Biotechnology
PBYI
PBYI
69 hedge funds and large institutions have $67.6M invested in Puma Biotechnology in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 20 increasing their positions, 23 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
2.79% less ownership
Funds ownership: 56.9% → 54.1% (-2.8%)
13% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 23
28% less capital invested
Capital invested by funds: $93.8M → $67.6M (-$26.2M)
Holders
69
Holding in Top 10
1
Calls
$1.01M
Puts
$201K
Top Buyers
| 1 | +$729K | |
| 2 | +$434K | |
| 3 | +$262K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$129K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$76.6K |
Top Sellers
| 1 | -$2.04M | |
| 2 | -$448K | |
| 3 | -$405K | |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
-$284K |
| 5 |
Two Sigma Advisers
New York
|
-$223K |